Coronary Stents Market Analysis by Product, End Use, Region & Forecasts to 2030

The global coronary stents market reached a value of USD 9.32 billion in 2022 and is projected to grow at a steady rate, with a revenue compound annual growth rate (CAGR) of 3.3% during the forecast period. The rise in cases of cardiovascular diseases (CVDs) such as heart disease and stroke is a major factor driving demand for coronary stents.

Coronary stents are small mesh tubes used to open narrowed or blocked arteries in the heart. They are widely used in procedures to treat coronary artery disease and have become an essential tool in modern cardiac care. The growing number of people affected by CVDs globally has increased the need for effective treatment options, contributing to the expansion of this market.

Several risk factors are linked to the development of heart disease and stroke, including high blood pressure, high cholesterol, diabetes, smoking, exposure to secondhand smoke, obesity, unhealthy diet, and lack of physical activity. Coronary stents help manage the complications arising from these conditions by improving blood flow and reducing the risk of serious cardiac events.

Get a sample of the report @ https://www.emergenresearch.com/request-sample/2774

In addition, ongoing advancements in stent technology, including improvements in materials and design, are making these devices safer and more effective. These innovations are expected to further support market growth in the coming years.

The increasing prevalence of coronary artery diseases (CAD) due to aging, poor diets, and sedentary lifestyles has heightened the demand for coronary stents. In September 2024, an article published in Biomedical and Environmental Sciences reported that cardiovascular disease (CVD) remains a leading health threat in China, exacerbated by an aging population and unhealthy lifestyles. Innovations in stent design, such as bioresorbable and drug-eluting stents, have improved their effectiveness and reduced complications, further driving market growth. Enhanced healthcare infrastructure and greater awareness of CAD treatments also contribute to more patients seeking stent-based interventions.

Coronary Stents Market Dynamics

The global coronary stents market is witnessing steady growth, largely driven by the rising prevalence of cardiovascular diseases (CVDs) and the increasing adoption of minimally invasive procedures. According to the British Heart Foundation's January 2024 report, an estimated 620 million people globally were living with heart disease, with around 250 million cases specifically attributed to coronary heart disease (CHD) in 2021. This growing burden of cardiovascular conditions underscores the critical need for effective treatment solutions such as coronary stents.

Coronary stents are essential medical devices used to restore and maintain blood flow in narrowed or blocked arteries. By keeping arteries open, these stents help prevent heart damage and support better long-term cardiovascular outcomes. Their widespread use in procedures such as angioplasty plays a vital role in addressing the challenges associated with CHD and other heart-related conditions.

Supporting this trend, data released by the UK government in March 2024 revealed that 1,862,500 people were diagnosed with coronary heart disease in England alone for the financial year ending in 2023. This high patient population continues to fuel the demand for coronary stents, which are commonly used during angioplasty to ensure effective and sustained arterial function.

Moreover, the rise in minimally invasive procedures such as percutaneous coronary intervention (PCI) is significantly contributing to market expansion. According to Eurostat data published in October 2023, approximately 1.1 million coronary angioplasty procedures were conducted across Europe in 2021. These procedures typically involve the insertion of stents using balloon catheters to treat blocked arteries and restore normal blood circulation to the heart muscle.

As the prevalence of CVDs continues to increase alongside a growing preference for less invasive treatment methods, the coronary stents market is expected to experience sustained growth over the forecast period.

Some major players included in the global coronary stents market report are:

Abbott Laboratories, Boston Scientific Corporation, Medtronic plc, Terumo Corporation, Johnson & Johnson, B. Braun Melsungen AG, C. R. Bard (acquired by BD), BIOTRONIK SE & Co. KG, Cook Medical, MicroPort Scientific Corporation, Meril Life Sciences, Vascular Concepts (acquired by Terumo Corporation), Stentys SA, Elixir Medical Corporation, Translumina GmbH, Sinomed, Hexacath, Alvimedica, Biotronik SE & Co. KG, Kyoto Medical Planning Co., Ltd.

Coronary Stents Market https://www.emergenresearch.com/industry-report/coronary-stents-market

14671 110 Avenue, Surrey, British Columbia, V3R2A9
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Visit for More Insights: https://www.emergenresearch.com/insights

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

This release was published on openPR.